Repeated IVF Failure: Patterns That Persist When Protocols Change

Medical Disclaimer: This article is for educational purposes only and is not medical advice. Always consult your physician or qualified healthcare provider for medical decisions. Full disclaimer at the bottom of this page.

Repeated IVF failure refers to two or more unsuccessful IVF cycles where the outcome does not change despite protocol adjustments. In most cases, this reflects underlying biological factors that have not been evaluated between cycles.

This article is for you if:

  • IVF has failed more than once and no one has explained why

  • You have been told to try again without a clear picture of what drove the last outcome

  • You have good embryos that did not implant

  • You are preparing for another cycle and want to understand what the biology is telling you first

I hear from women all the time who have done everything right. They followed the protocol. They took the supplements their clinic recommended. They showed up for every appointment. And they still have no baby.

When IVF fails once, it is devastating. When it fails twice or three times with the same outcome -- embryos arresting, transfers not implanting, cycles producing less each time -- the explanation you are usually given is that it is a numbers game. Try again. Adjust the protocol. Change the stimulation dose.

But here is what I have seen consistently across the cases we review at Fab Fertile: repeated IVF failure is not a protocol problem. It is a biological environment problem. And the environment is built in the months before retrieval -- not during stimulation.

IVF is a remarkable tool. It can retrieve eggs, fertilize them, culture embryos, and transfer at the optimal moment. What it cannot do is change what those eggs were developing in for the 90 days before they were retrieved. That is where the pattern lives. And that is almost never what gets evaluated between cycles.

I covered this in depth on the podcast -- Why IVF Failure Is Not Bad Luck -- and what comes through in every conversation is the same thing: the biology between cycles was never looked at. The protocol changed. The biology did not.

Embryo Audit Checklist

Why IVF Keeps Failing Even When Protocols Change

When IVF fails more than once despite protocol adjustments, these are the contributors most consistently missed in a standard workup:

The biological environment -- mitochondrial function, inflammatory load, thyroid signaling, nutrient status -- was not evaluated or addressed between cycles

Sperm DNA integrity was never assessed. Standard semen analysis does not measure it

Immune and inflammatory factors that disrupt implantation were not investigated

The endometrial environment, including microbiome balance, was not evaluated in cases with normal embryos failing to implant

Changing the protocol addresses stimulation. It does not address any of these. Success rates typically decline after multiple failed cycles -- which is why identifying what has not been evaluated becomes more important with each cycle, not less.


Why New Protocols Often Yield the Same Results

The conversation after a failed IVF cycle almost always goes the same way. The clinic reviews what happened, adjusts the stimulation protocol, and books the next cycle. Sometimes they suggest a different medication. Sometimes a different transfer timing. Sometimes a different clinic entirely.

None of that changes what the eggs and sperm are developing in. Protocols control stimulation -- follicle growth, hormone levels, timing. They do not alter the biological environment that shaped those eggs during the prior 90 days.

If metabolic function, inflammatory status, thyroid signaling, gut health, nutrient status, and sperm DNA integrity have not been addressed between cycles, the next cycle begins with the same inputs. The protocol is different. The biology is the same.

This is something I talk about directly in the podcast episode Why Rushing Into the Next IVF Cycle Often Backfires. The pressure to move quickly is real and I understand it. But moving quickly into the same biology is not moving forward.

Whether a cycle costs $5,000 or $20,000 -- and many clinics sell packages of multiple cycles because repeat attempts are expected -- repeating without understanding why the last one failed means investing in the same biology that produced the same outcome. Health has to come first, or the investment keeps producing the same result.


IVF Failed Twice or More: What Changes at This Point

Two failed cycles is not bad luck. It is a signal that something in the biological picture has not been identified.

When IVF has failed twice, the pattern is likely. When it has failed three or more times, systemic contributors are almost always present -- contributors that sit entirely outside what a standard workup evaluates. Thyroid autoimmunity. Sperm DNA fragmentation. Gut-driven inflammation. Immune dysregulation. Nutrient malabsorption. These do not show up on a standard cycle review. They require a different kind of evaluation.

And yet the default is to book another cycle. I see this all the time. Three failed cycles. Thousands of dollars spent. And the biological environment has never been looked at between any of them. The same pattern going into each one.

We put together a full audit framework for this -- the Failed IVF Cycle Audit podcast episode -- because the question after a failed cycle should not be which protocol to try next. It should be what the pattern is telling us.


The Biology Behind Repeated IVF Failure

Embryo Development and Energy Demand

When embryos arrest between Day 3 and Day 5, what we are usually seeing is an energy problem, not a random chromosomal event. Early division can look completely normal -- and then development slows or stops at the exact point where the embryo activates its own genome and energy demand surges.

That surge requires mitochondrial function in the oocyte that was built during the 90-day development window before retrieval. If CoQ10 in the follicular fluid is depleted -- which happens with age, chronic inflammation, and oxidative stress -- the embryo does not have the cellular fuel it needs to cross that threshold. The Hart 2023 evidence review confirmed that CoQ10 levels in follicular fluid decline with age and that low CoQ10 status correlates directly with oocyte chromosome abnormalities. This is not a stimulation problem. It is a preparation problem. And it is addressable in the 90 days before the next cycle.

In our case reviews, when embryos arrest at the same stage across multiple cycles, this is the first pattern we investigate. The consistency of the arrest point is the signal.

Hart RJ et al. Nutritional supplements and IVF: an evidence-based approach. Reproductive BioMedicine Online. 2023.

Implantation and the Endometrial Environment

Chromosomally normal embryos that fail to implant are one of the most frustrating patterns in IVF -- and one of the most misunderstood. When the embryo is good and the transfer goes well and nothing happens, the explanation is almost always attributed to bad luck or unexplained factors. But there is nothing unexplained about it when you look at the full picture.

The endometrium is not a passive surface. It is an active biological environment shaped by immune signaling, microbiome balance, inflammatory status, and hormonal support. When any of those are off, implantation fails -- even with a perfect embryo. A 2025 review confirmed that loss of protective Lactobacillus species in the endometrial microbiome is independently associated with failed implantation. This is almost never evaluated in a standard workup.

Gut dysbiosis upstream compounds the problem. The gut influences estrogen metabolism, immune regulation, and gonadotropin signaling through the gut-ovarian axis. When it is dysregulated, it drives the kind of chronic low-grade inflammation that lands in the endometrium and disrupts the receptivity window. I cover the gut connection specifically because it is so consistently missed -- if you have had ongoing digestive issues, skin conditions, or a history of antibiotic use without microbiome support, that history is relevant to your IVF outcomes.

The podcast episode Before Your IVF Transfer: Test This First goes into the specific markers we look at before transfer -- because what gets evaluated in that window determines what the transfer has to work with.

I also covered this in the blog post Why IVF Fails With Good Embryos -- because good embryos failing to implant is a specific pattern with specific contributors. It is not random.

Precision Microbial Therapeutics for Infertility: vaginal microbiome and implantation. PubMed. 2025. 

Wang M et al. Gut microbiota: emerging biomarkers for infertility-related diseases. Front Cell Infect Microbiol. 2024. 

Sperm Contribution to Embryo Development

Poor embryo development gets blamed on egg quality so consistently that the sperm contribution often never gets evaluated. But sperm contributes half the genetic material and half the mitochondrial signaling that drives early embryo development -- and standard semen analysis tells you nothing about DNA integrity.

A 2025 study of 870 ICSI cycles found that each 1% increase in sperm DNA fragmentation reduced the odds of achieving a top-quality Day 5 blastocyst by 2.5%. In a cycle where only two or three eggs are retrieved, that effect is not statistical noise -- it determines whether the cycle produces a viable embryo. And in most of the cases we review where IVF has failed multiple times with poor embryo development, sperm DNA fragmentation has never been tested.

I dedicated a full podcast episode to this -- Normal Semen Analysis, Failed IVF -- because the disconnect between a normal semen analysis and a failed cycle is one of the most common patterns we see. Normal count and motility does not mean normal DNA integrity.

In our case reviews, sperm DNA fragmentation testing is non-negotiable when IVF has failed more than once. It is that consistently overlooked.

Sperm DNA Fragmentation Impairs Early Embryo Development: insights from 870 ICSI cycles. MDPI Int J Mol Sci. 2025. 


From Three Failed IVF Cycles to a Healthy Pregnancy: Heather's Story

"I had done everything right. Three IVF cycles. I had followed every protocol. And I still had no baby."

Heather came to Fab Fertile after three failed IVF cycles, a miscarriage, and a diagnosis of diminished ovarian reserve (DOR). She had changed clinics. She had changed protocols. The outcome had not changed.

What had never changed was the biological environment those eggs were developing in. When we reviewed her full picture -- thyroid antibodies, inflammatory markers, gut health, nutrient status, sperm DNA fragmentation -- there were contributors in almost every category that had never been evaluated between cycles.

Heather went on to conceive her daughter through the Fab Fertile Method. Nothing about her protocol changed first. The biology did.

Read Heather's full story

Five Patterns We Consistently Find in Repeated IVF Failure Cases

When we do a second opinion case review at Fab Fertile, we are not looking at the cycle in isolation. We are looking at what the body has been doing for months or years before that cycle started. And across repeated IVF failure cases, the same patterns surface -- not occasionally, but consistently.

You do not need all five. Most cases show one or two clearly. But you cannot know which ones until the right markers are assessed. What I can tell you is that in the cases we review, it is rare to find nothing when you look.

Pattern 1: Signaling Disruption

The hormonal communication between the hypothalamus, pituitary, and ovaries is more fragile than most people realize. Subclinical thyroid dysfunction -- the kind that falls within the standard reference range -- can impair follicle development, reduce egg quality, and undermine implantation without producing any symptoms that would trigger further investigation.

The pattern we see most consistently is not a TSH that is dramatically off. It is thyroid autoimmunity -- elevated thyroid peroxidase antibodies -- sitting quietly in the background, managed and filed away, not considered part of the fertility picture. A 2025 meta-analysis confirmed that thyroid antibodies have been detected directly in follicular fluid and create a cytotoxic environment that impairs oocyte maturation. Hashimoto's is not just a thyroid condition. In the context of IVF, it is an ovarian environment condition.

The functional reference range we use for TSH is 0.5 to 2.0 mIU/mL. We also evaluate Reverse T3 -- when it is elevated, the body is converting available thyroid hormone into an inactive form, a stress-state adaptation that signals the body is deprioritizing reproduction. This is not captured on a standard TSH panel and is not something a typical fertility workup checks for.

The conversation I hear all the time: TSH was checked, it was normal, nobody mentioned antibodies. Two failed cycles later and the antibodies have never been run.

Hashimoto's Thyroiditis and Female Fertility: Endocrine, Immune, and Microbiota Perspectives. PMC. 2025. 

American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. 2024. 

Pattern 2: Inflammatory Load

Chronic systemic inflammation interferes with every stage of the IVF cycle -- follicle development, fertilization, embryo quality, and endometrial receptivity. The Institute for Functional Medicine (IFM) has documented that inflammatory signaling is independently associated with accelerated ovarian aging and poorer embryo outcomes. And the problem with inflammation in this context is that it is usually silent. There are no obvious symptoms. Standard IVF prep does not check for it.

The markers we look at first are high-sensitivity C-reactive protein (hsCRP) and homocysteine. Functional targets: hsCRP below 1 mg/L, homocysteine between 6.0 and 7.2 micromol/L. When either is elevated, it tells us the environment those eggs are developing in is under inflammatory stress that has not been addressed.

Gut dysbiosis is frequently the upstream driver. When the gut lining is compromised, inflammatory signals move systemically and land in ovarian tissue, disrupting follicle recruitment and the hormonal signaling that supports a healthy cycle. This is why gut health is part of every repeated IVF failure case review we do -- it is upstream of almost everything else.

If you want to understand how gut health connects to hormone balance and fertility outcomes, I covered this in depth in the blog post Gut Health and Hormone Balance: What Every Woman Trying to Conceive Needs to Know.

The gut-fertility connection runs deeper than most people realize -- I covered exactly how it affects egg quality, low AMH, and high FSH in the podcast episode Improving Egg Quality and Fertility: The Gut-Fertility Connection. The same mechanisms driving poor egg quality are driving poor IVF outcomes.

And if you have been told inflammation is not relevant to your fertility picture, the podcast episode Beyond Hormones: Why Inflammation May Be Driving Poor Egg Quality and Miscarriage is worth listening to before your next cycle.

The pattern we often see: a history of gut symptoms, skin conditions, or chronic infections that were never connected to the fertility picture. The inflammation was always there. It just was not being measured.

IFM. The Inflammatory Response and Reproductive Health. https://www.ifm.org/articles/the-inflammatory-response-and-reproductive-health

Pattern 3: Metabolic Instability

Insulin resistance and blood sugar dysregulation impair mitochondrial function, disrupt ovarian signaling, and alter the hormonal environment that follicles develop in. This does not require a diabetes diagnosis. Subclinical insulin resistance -- the kind that does not show up on a standard metabolic panel -- can affect egg quality and embryo development without any obvious signs.

Fasting insulin and HOMA-IR are the markers that surface this pattern. A normal fasting glucose does not rule it out. We also look at ferritin -- functional target 80 to 100 ng/mL -- as a combined marker of iron status and metabolic inflammation. Low ferritin impairs mitochondrial energy production directly. High ferritin suggests inflammatory load. Both affect egg quality in ways that stimulation protocols cannot compensate for.

Nutrition matters here in very specific ways. Oat milk, often positioned as a healthy swap, causes significant blood sugar spikes and is not a useful choice when metabolic stability is the goal. The elimination of gluten for 60 to 90 days, paired with food sensitivity, gut, and genetic testing, is a more targeted starting point than a generic clean eating recommendation.

MTHFR is another piece of this picture that rarely gets discussed in fertility workups. If you have not looked at your methylation status, the blog post MTHFR, Methylation, and Fertility is worth reading -- particularly if you have been taking standard folic acid rather than methylfolate.

The distinction between folic acid and methylfolate matters more than most people realize. I covered it specifically in the context of high FSH and low AMH in Methylfolate vs Folic Acid: What You Need to Know.

Blood sugar dysregulation is one of the most underappreciated drivers of poor IVF outcomes. The podcast episode Blood Sugar and Egg Quality: The Fertility Link You Cannot Ignore covers exactly why this matters and what to do about it -- because the food choices happening 90 days before retrieval are shaping the eggs going into that cycle.

The pattern we often see: someone eating what she believes is a healthy diet, normal A1C, fasting insulin never tested, and a supplement stack that includes standard folic acid when her MTHFR status means it is not being properly converted.

Pattern 4: Immune Activation

Immune dysregulation is one of the most under-evaluated contributors to repeated IVF failure -- and one of the most impactful when it is finally identified. The endometrium needs to undergo a controlled immune response to allow implantation. When systemic immune activation is present, that window gets disrupted. The body treats the embryo as a threat rather than allowing it to implant.

Thyroid antibodies are the most common immune marker we find. But antinuclear antibodies (ANA), antiphospholipid antibodies, and natural killer cell activity are also relevant in cases with normal embryos and repeated implantation failure. These are not routinely assessed in a standard REI workup. And they can be the entire reason a chromosomally normal embryo does not implant.

The podcast episode Autoimmune Roadblocks to IVF: How ANA Affects Fertility goes into this directly -- because ANA positivity in fertility is one of the patterns that gets missed most consistently, and its impact on IVF outcomes is significant.

Ureaplasma is another immune disruptor that rarely gets discussed. It is a bacterial infection that can sit silently in the reproductive tract and trigger an immune response that undermines implantation. I covered it in the podcast episode The Hidden Threat: Ureaplasma's Impact on IVF Success. If you have had multiple failed transfers with no explanation, this is worth investigating.

The broader immune picture -- how inflammatory signaling, autoimmune activity, and immune dysregulation intersect with fertility outcomes -- is covered in the featured article Inflammation, Immune Signaling, and Fertility Outcomes: A Pattern-Based View.

The pattern we often see: two or three chromosomally normal embryos transferred, none implanted, no immune workup ever done. The embryo was not the problem.

Pattern 5: Nutrient Depletion

The 90 days before retrieval are the most important nutritional window in the IVF process. Mitochondrial function in the developing oocyte depends on CoQ10, B vitamins, vitamin D, omega-3 fatty acids, and adequate iron -- and deficiencies in any of these directly impair the energy production that embryo development requires.

Most people who come to us for a second opinion are already taking supplements. That is not the problem. The problem is that the supplements were chosen without testing what the body actually needs -- and in many cases, the gut is not absorbing them efficiently enough for them to reach the follicle. CoQ10 that is not absorbing is not doing anything. The 2025 meta-analysis across 16 studies and 2,773 women confirmed that targeted supplementation for more than two months significantly improved high-quality embryo rate and clinical pregnancy in diminished ovarian reserve. The mechanism is mitochondrial. But it only works if the foundation is right.

Functional targets we use: vitamin D 60 to 80 ng/mL, B12 800 to 900 pg/mL, ferritin 80 to 100 ng/mL. These are not the same as standard laboratory reference ranges. DHEA is frequently discussed in the context of poor ovarian response -- it may be appropriate in confirmed androgen deficiency, but it requires DHEA-S testing first. Supplementing without that baseline can drive androgen excess and create new hormonal imbalance.

The podcast episode Embryo Transfer Prep: The Hidden Factors That Could Make or Break Success covers the specific preparation markers we assess before a transfer -- because what you do in the 90-day window before retrieval and in the lead-up to transfer determines what the cycle has to work with.

Ferritin specifically is one of the most consistently low markers we find and one of the least discussed in IVF prep. The podcast episode Ferritin, Iron Deficiency, and Fertility covers why ferritin matters far beyond basic iron levels -- and why the standard reference range misses the functional target completely.

The pattern we often see: a full supplement stack assembled without any baseline testing, a gut that has never been assessed, and supplements that are working against the pattern rather than with it.

The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis. PMC. 2025. 


The 90-Day Window Before IVF: Why It Determines What the Cycle Has to Work With

Every egg retrieved in an IVF cycle began developing approximately 90 days earlier. The biological environment during those three months -- nutrient availability, mitochondrial energy production, inflammatory load, insulin regulation, thyroid signaling -- directly shapes the quality of the eggs going into that cycle.

When that environment has not been evaluated or addressed, the next cycle inherits the same conditions as the last one. This is the most consistent finding in second opinion case reviews: the biology between cycles was never assessed. The protocol changed. The biology did not.

This is the purpose of the 90-day preparation window -- not to delay IVF, but to change what IVF has to work with. The Fab Fertile approach works alongside IVF, not instead of it. The goal is to go into the next cycle with a genuinely different biological environment.

We cover the shared biological environment -- both egg and sperm -- in the blog post The Shared Environment: Why Unexplained IVF Failure Is Often Untested. It is one of the most important pieces of context for understanding why the same outcome keeps repeating.


Most people do not stop here. They move straight into another cycle.

Before you commit to another cycle, this is the point where stepping back changes the trajectory.

If nothing has changed between cycles, repeating another one usually means repeating the same outcome.

Start with a Functional Fertility Second Opinion

Why Most Plans for Repeated IVF Failure Miss the Full Picture

You were told the next step is a different protocol, a different stimulation approach, maybe a different clinic.

But the biological environment those eggs are developing in -- the one that was present for the last cycle and the one before it -- has not been evaluated. Protocol changes optimize timing and dosing. They do not address mitochondrial function, inflammatory status, immune signaling, gut health, or sperm DNA integrity.

You were told the embryos arrested because of egg quality.

But egg quality is a product of the environment those eggs developed in over the prior 90 days. If that environment has not changed between cycles, the next retrieval begins with the same inputs.

The biology of egg quality -- what mitochondrial function actually means for fertilization and embryo development -- is covered in depth in the featured article Egg Quality and Ovarian Signaling: Why Age Alone Does Not Explain Outcomes.

You were told the transfer failed because of bad luck, or because chromosomal issues are common.

But chromosomally normal embryos can fail to implant. And when they do -- repeatedly -- the question is the endometrial environment, the immune response, and the microbiome. Not luck.

The podcast episode Unexplained IVF Failure: What's Often Missed Before You Try Again addresses this pattern directly -- because the unexplained label does not mean there is nothing to find. It means the right questions have not been asked yet.


A Functional Fertility Audit: Repeated IVF Failure

This is where most people realize what has been missed. The table below compares what a standard workup evaluates against what a Functional Fertility pattern review looks for.


Area

Conventional View

Fab Fertile Pattern Interpretation

Thyroid and Autoimmunity

TSH checked. Antibodies rarely included in a repeated IVF failure workup.

Full thyroid panel including Free T3, Free T4, Reverse T3, and thyroid antibodies. Thyroid peroxidase antibodies are independently associated with implantation failure even with normal TSH.

The pattern: two or more failed cycles, TSH within range, antibodies never checked.

Inflammation

Inflammatory markers not routinely assessed as part of IVF preparation.

hsCRP and homocysteine evaluated as indicators of systemic inflammatory burden. Functional targets: hsCRP below 1 mg/L, homocysteine 6.0 to 7.2 micromol/L. The pattern: chronic gut symptoms or skin conditions that have never been connected to the fertility picture.

Gut Health

Not considered part of fertility evaluation.

Gut dysbiosis is an upstream driver of inflammation, immune dysregulation, and nutrient malabsorption -- all of which directly affect IVF outcomes. The endometrial microbiome is also evaluated when implantation has failed repeatedly with chromosomally normal embryos.

Metabolic Status

Standard metabolic panel. Fasting glucose. Prenatal vitamin recommended.

Fasting insulin, HOMA-IR, and ferritin as functional markers. Mitochondrial cofactors assessed based on the individual pattern. Supplement stack reviewed for absorption and alignment with actual deficiencies -- not assumed needs.

Immune Signaling

Immune workup not routinely included unless recurrent implantation failure is specifically flagged.

Antinuclear antibodies, antiphospholipid antibodies, and broader immune markers where the history points to autoimmune involvement. Natural killer cell activity considered in cases with repeated implantation failure and normal embryos. Ureaplasma evaluated where microbiome disruption is suspected.

Male Factor

Standard semen analysis -- count, motility, morphology. Repeated between cycles if results were previously normal.

Sperm DNA fragmentation testing. A standard semen analysis does not assess DNA integrity. Each 1% increase in fragmentation reduces top-quality Day 5 blastocyst odds by 2.5%. This is almost never tested between failed IVF cycles.

Egg and Embryo Environment

Response to stimulation reviewed. Protocol adjusted for next cycle.

The 90-day development window evaluated for the inputs that shaped the last retrieval -- mitochondrial support, nutrient status, inflammatory load, thyroid signaling. If those inputs have not changed, the next retrieval begins with the same biology.



When Repeated IVF Failure Overlaps With Diminished Ovarian Reserve

A significant number of the cases we review involve both repeated IVF failure and diminished ovarian reserve (DOR). These two diagnoses together are often presented as a reason to move quickly to donor eggs. And I understand why. The reserve picture is real and age matters.

If low AMH is part of your picture, the featured article Low AMH in Context: What the Number Signals and What It Does Not [link when live] covers what the number is actually telling you -- and what it is not -- because AMH is frequently misread as a final verdict when it is a starting point for a much bigger conversation.

And if diminished ovarian reserve is part of the picture alongside repeated failure, the featured article Diminished Ovarian Reserve: Interpreting Capacity Versus Potential [link when live] addresses the biological contributors that are almost never evaluated before the donor egg conversation starts.

But the biological environment underneath the reserve markers -- the inflammation, the thyroid autoimmunity, the metabolic picture, the gut health -- is almost never fully evaluated before that conversation happens. And in many cases, those contributors are shaping both the reserve numbers and the cycle outcomes.

I dedicated a full episode to navigating this intersection -- DOR and IVF: Essential Insights for Your Next Cycle -- because the decision about what to do next looks very different when you have the full picture in front of you.


FAQ: Repeated IVF Failure

Why does IVF keep failing?

When IVF fails more than once with no clear explanation, the most common reason is that the biological environment has not been evaluated between cycles. Protocol changes optimize stimulation and timing. They do not address mitochondrial function, immune signaling, gut health, thyroid status, or sperm DNA integrity. Repeated failure is a pattern -- and patterns have identifiable biological contributors.

Why did my IVF fail twice?

Two failed cycles is a signal that something in the biological picture has not been identified. The most consistently missed contributors are sperm DNA fragmentation, thyroid autoimmunity, systemic inflammation, and endometrial microbiome imbalance. None of these are captured in a standard IVF workup or cycle review.

What causes repeated implantation failure?

When chromosomally normal embryos fail to implant, the question is the environment they were transferred into -- not the embryo itself. The areas most consistently overlooked are the endometrial microbiome, systemic immune activation, thyroid autoimmunity, and gut-driven inflammation. These are solvable patterns when they are properly evaluated.

What to do after failed IVF?

Before committing to another cycle, the most valuable step is understanding what the biology behind your cycles is telling you. A Functional Fertility evaluation assesses the specific contributors to past failure -- thyroid signaling, inflammatory load, gut health, nutrient status, sperm DNA integrity -- and builds a preparation strategy for the next cycle. That is not a delay. It is the difference between repeating the same inputs and preparing different biology.

Can anything be done differently before the next IVF cycle?

Yes -- and the 90-day window before the next retrieval is when it matters most. If the biological environment that shaped the last cycle has not changed, the next one begins with the same inputs. Addressing the contributors to past failure in that window changes what the next cycle has to work with.


Pregnancy After Repeated IVF Failure: Cases From the Fab Fertile Community

Styling: Display this section in highlighted box per design spec

These are not outliers. They are what becomes possible when the full biological picture is evaluated and addressed -- not just the cycle outcomes.


What the Research Shows

The research on repeated IVF failure consistently points away from protocol adjustment and toward the biological environment between cycles.

Sperm DNA fragmentation is one of the most documented contributors to poor embryo outcomes that standard workup misses. The 2025 study of 870 ICSI cycles established a direct dose-response relationship: each 1% increase in fragmentation reduces the odds of a top-quality Day 5 blastocyst by 2.5%. In cases with low egg yield, this effect is not diluted -- it determines the cycle.

The endometrial microbiome has emerged as a significant determinant of implantation success. Loss of Lactobacillus dominance in the endometrium is independently associated with failed implantation, and it is almost never assessed in standard workup.

Thyroid autoimmunity is independently associated with poorer embryo quality and lower implantation rates in IVF even when TSH is normal. A 2025 meta-analysis confirmed that thyroid peroxidase antibodies have been detected directly in follicular fluid -- meaning the immune activation reaches the oocyte directly, not just systemically.

Mitochondrial function within the oocyte -- not egg number -- drives whether retrieved eggs produce viable embryos. The Hart 2023 evidence review documented that CoQ10 in follicular fluid declines with age and correlates directly with chromosomal competence. This is the biological foundation for why 90-day preparation changes what IVF has to work with.

Targeted nutritional supplementation for more than two months before IVF significantly improved high-quality embryo rate and clinical pregnancy across a 2025 meta-analysis of 16 studies and 2,773 women with diminished ovarian reserve. CoQ10 had the strongest and most consistent evidence base. The mechanism is mitochondrial.


The Case for a Second Opinion Before the Next Cycle

If IVF has failed twice or more and the explanation has been protocol-based -- not biology-based -- the question worth asking before the next cycle is whether the full picture has been evaluated.

In most of the cases we review at Fab Fertile, the failed cycles were real. The outcomes were not bad luck. There were biological contributors -- across thyroid signaling, inflammation, gut health, immune activation, nutrient status, and sperm DNA integrity -- that had never been assessed between cycles. When they were, there was a different picture to work with.

A second opinion is not about disputing what your clinic has done. It is about understanding what the biology behind your cycles is telling you -- before you invest in another cycle that begins with the same inputs.

Because repeating another cycle without understanding why the last ones failed is how the same outcome happens again.

Start with a Functional Fertility Second Opinion

Or begin with the Embryo Audit Checklist to review what may have been missed before your next decision.


Related Podcast Episodes and Blog Posts

Why IVF Failure Is Not Bad Luck

Why Rushing Into the Next IVF Cycle Often Backfires

Before Your IVF Transfer: Test This First

Autoimmune Roadblocks to IVF: How ANA Affects Fertility

DOR and IVF: Essential Insights for Your Next Cycle

Normal Semen Analysis, Failed IVF

Why IVF Fails With Good Embryos

Unexplained IVF Failure: What's Often Missed Before You Try Again

The Shared Environment: Why Unexplained IVF Failure Is Often Untested

Failed IVF Cycle Audit

The Hidden Threat: Ureaplasma's Impact on IVF Success

Embryo Transfer Prep: The Hidden Factors That Could Make or Break Success

Gut Health and Hormone Balance: What Every Woman Trying to Conceive Needs to Know

Improving Egg Quality and Fertility: The Gut-Fertility Connection

Beyond Hormones: Why Inflammation May Be Driving Poor Egg Quality and Miscarriage

Blood Sugar and Egg Quality: The Fertility Link You Cannot Ignore

Ferritin, Iron Deficiency, and Fertility

Beyond Hormones: Why Inflammation May Be Driving Poor Egg Quality and Miscarriage

Blood Sugar and Egg Quality: The Fertility Link You Cannot Ignore

Ferritin, Iron Deficiency, and Fertility: What Your Numbers Are Telling You

Improving Egg Quality and Fertility: The Gut-Fertility Connection

Methylfolate vs Folic Acid: What You Need to Know

MTHFR, Methylation, and Fertility


Sources and Research

Hart RJ et al. Nutritional supplements and IVF: an evidence-based approach. Reproductive BioMedicine Online. 2023

Sperm DNA Fragmentation Impairs Early Embryo Development: insights from 870 ICSI cycles. MDPI Int J Mol Sci. 2025. 

Precision Microbial Therapeutics for Infertility: vaginal microbiome and implantation. PubMed. 2025. 

Wang M et al. Gut microbiota: emerging biomarkers for infertility-related diseases. Front Cell Infect Microbiol. 2024. 

Hashimoto's Thyroiditis and Female Fertility: Endocrine, Immune, and Microbiota Perspectives. PMC. 2025. 

The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: meta-analysis. PMC. 2025. 

IFM. The Inflammatory Response and Reproductive Health. 

American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. 2024. 

Reviewed by Dr. Labib Ghulmiyyah, MD

Board Certified in Obstetrics and Gynecology
Board Certified in Maternal Fetal Medicine
Certified in Functional Medicine

This content has been reviewed for alignment with the Fab Fertile clinical framework. The biological patterns and systems-based interpretations discussed in this article reflect the methodology used in Functional Fertility Second Opinion case reviews.

Dr. Labib contributes physician-level perspective to the Fab Fertile clinical framework in an advisory capacity. Clients remain under the care of their own treating physicians for all medical decisions.

Connect with Dr. Labib on LinkedIn

CURRENT VERSION VERIFIED APRIL 2026

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking care because of something you have read on this website.